Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-10 8:13 pm Purchase | 2024-11-20 | 13G | Forte Biosciences, Inc. FBRX | Nemean Asset Management, LLC | 432,276 6.760% | 432,276 (New Position) | Filing History |
| 2024-04-29 11:44 am Purchase | 2024-04-22 | 13G | Benitec Biopharma Inc. BNTC | Nemean Asset Management, LLC | 791,235 8.890% | 693,032 (+705.71%) | Filing History |
| 2023-08-18 10:50 am Sale | 2023-08-08 | 13G | Benitec Biopharma Inc. BNTC | Nemean Asset Management, LLC | 98,203 3.890% | -24,395 (-19.90%) | Filing History |
| 2022-10-07 12:46 pm Purchase | 2022-09-14 | 13G | Benitec Biopharma Inc. BNTC | Nemean Asset Management, LLC | 122,598 8.080% | 83,297 (+211.94%) | Filing History |
| 2022-05-09 4:29 pm Sale | 2022-05-02 | 13G | Peak Bio, Inc. PKBOW | Nemean Asset Management, LLC | 0 0.000% | -400,000 (Position Closed) | Filing History |
| 2022-03-09 11:18 am Purchase | 2022-03-07 | 13G | Trevi Therapeutics, Inc. TRVI | Nemean Asset Management, LLC | 1,340,000 5.180% | 1,340,000 (New Position) | Filing History |
| 2022-03-02 5:24 pm Sale | 2022-02-23 | 13G | 4D pharma plc LBPS | Nemean Asset Management, LLC | 8,913,432 4.940% | -1,305,000 (-12.77%) | Filing History |
| 2022-02-03 10:39 am Sale | 2022-02-02 | 13G | 4D pharma plc LBPS | Nemean Asset Management, LLC | 10,218,432 5.670% | -10,664,994 (-51.07%) | Filing History |
| 2022-01-19 3:20 pm Purchase | 2022-01-18 | 13G | Renovacor, Inc. RCOR | Nemean Asset Management, LLC | 575,000 3.330% | 575,000 (New Position) | Filing History |
| 2021-09-21 1:31 pm Sale | 2021-09-07 | 13G | Forte Biosciences, Inc. FBRX | Nemean Asset Management, LLC | 0 0.000% | -26,043 (Position Closed) | Filing History |
| 2021-04-14 5:17 pm Purchase | 2021-04-12 | 13G | Benitec Biopharma Inc. BNTC | Nemean Asset Management, LLC | 39,301 13.870% | 16,061 (+69.11%) | Filing History |
| 2021-04-12 06:09 am Purchase | 2021-03-22 | 13G | 4D pharma plc LBPS | Nemean Asset Management, LLC | 20,883,426 11.670% | 20,883,426 (New Position) | Filing History |
| 2021-04-05 06:01 am Purchase | 2021-04-01 | 13G | Benitec Biopharma Inc. BNTC | Nemean Asset Management, LLC | 23,240 8.200% | 23,240 (New Position) | Filing History |
| 2021-02-16 3:20 pm Purchase | 2020-12-31 | 13G | Forte Biosciences, Inc. FBRX | Nemean Asset Management, LLC | 26,043 5.100% | 3,600 (+16.04%) | Filing History |
| 2021-02-16 3:16 pm Purchase | 2021-02-16 | 13G | LONGEVITY ACQUISITION CORP USD LOAC | Nemean Asset Management, LLC | 212,479 8.100% | 37,293 (+21.29%) | Filing History |
| 2021-02-16 2:51 pm Sale | 2020-12-31 | 13G | Monterey Capital Acquisition Corporation MCAC | Nemean Asset Management, LLC | 0 0.000% | -650,000 (Position Closed) | Filing History |
| 2021-02-02 06:10 am Purchase | 2021-01-28 | 13G | Peak Bio, Inc. PKBOW | Nemean Asset Management, LLC | 400,000 6.300% | 400,000 (New Position) | Filing History |
| 2020-10-27 10:51 am Purchase | 2020-10-23 | 13G | LONGEVITY ACQUISITION CORP USD LOAC | Nemean Asset Management, LLC | 175,186 6.670% | 175,186 (New Position) | Filing History |
| 2020-09-01 09:10 am Purchase | 2020-08-28 | 13G | Forte Biosciences, Inc. FBRX | Nemean Asset Management, LLC | 22,443 5.010% | 22,443 (New Position) | Filing History |
| 2020-06-11 2:50 pm Purchase | 2020-06-04 | 13G | Monterey Capital Acquisition Corporation MCAC | Nemean Asset Management, LLC | 650,000 9.890% | 650,000 (New Position) | Filing History |